Experts Seek Alignment of Standards Recognition Across FDA’s CDER, CBER, CDRH

In comments to US Food and Drug Administration (FDA) February draft guidance, industry experts called on the agency for alignment of the approaches to voluntary consensus standards (VCS) recognition.